SmartPharmaRX Review
SmartPharmaRX is a 503A licensed compounding pharmacy compounding sterile preparations in accordance with USP 797 (with USP 795 / 800 alignment) and cGMP-aligned protocols. Compounds GLP-1 therapies including tirzepatide and semaglutide, with each preparation tested for sterility, potency, endotoxin, and stability before release. Specific state license footprint is described as 'select states' but not enumerated on the public site.
Medium confidence · Last verified 2026-05-23 via pharmacy-directory-cross-state-audit-2026-05-23 · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
SmartPharmaRX is a solid telehealth option with balanced features and pricing.
Score Breakdown
Sources & methodology
Our SmartPharmaRX review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
Alternatives to SmartPharmaRX
Absolute Pharmacy
Editorial score · methodology
Get StartedRead full Absolute Pharmacy review →